logo-loader

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$35.79 m
Price
0.22 USD
Change
5.64%
52 weeks high
0.69
52 weeks low
0.19

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.